Published in Biochem Pharmacol on March 01, 1995
ABC transporters as multidrug resistance mechanisms and the development of chemosensitizers for their reversal. Cancer Cell Int (2005) 1.83
A novel approach for predicting P-glycoprotein (ABCB1) inhibition using molecular interaction fields. J Med Chem (2011) 1.17
Effects of the selective bisindolylmaleimide protein kinase C inhibitor GF 109203X on P-glycoprotein-mediated multidrug resistance. Br J Cancer (1996) 1.00
Marine natural products with P-glycoprotein inhibitor properties. Mar Drugs (2014) 0.82
Synthesis of novel 1,8-acridinediones derivatives: Investigation of MDR reversibility on breast cancer cell lines T47D and tamoxifen-resistant T47D. Res Pharm Sci (2015) 0.75
Glycoproteins of cell surfaces. A comparative study of three different cell surfaces of the rat. J Biol Chem (1971) 5.25
Quantitative interpretation of age-specific mortality reductions from the Swedish breast cancer-screening trials. J Natl Cancer Inst (1995) 4.23
Endoscopic colorectal cancer screening: a cost-saving analysis. J Natl Cancer Inst (2000) 3.92
Nitric oxide synthase is not a constituent of the antimicrobial armature of human mononuclear phagocytes. J Infect Dis (1993) 3.75
Molecular weight determination of membrane protein and glycoprotein subunits by discontinuous gel electrophoresis in dodecyl sulfate. Methods Enzymol (1974) 3.50
Purification, molecular cloning, and expression of the mammalian sigma1-binding site. Proc Natl Acad Sci U S A (1996) 3.39
alpha 1D (Cav1.3) subunits can form l-type Ca2+ channels activating at negative voltages. J Biol Chem (2001) 2.77
Histone deacetylases 1, 2 and 3 are highly expressed in prostate cancer and HDAC2 expression is associated with shorter PSA relapse time after radical prostatectomy. Br J Cancer (2008) 2.67
Metabolic differentiation of distinct muscle types at the level of enzymatic organization. Eur J Biochem (1969) 2.49
Mutations in the Delta7-sterol reductase gene in patients with the Smith-Lemli-Opitz syndrome. Proc Natl Acad Sci U S A (1998) 2.22
Extra incidence caused by mammographic screening. Lancet (1994) 2.19
The MISCAN-COLON simulation model for the evaluation of colorectal cancer screening. Comput Biomed Res (1999) 1.98
Nationwide breast cancer screening programme fully implemented in The Netherlands. Breast (2001) 1.88
Plasma membrane protein subunit composition. A comparative study by discontinuous electrophoresis in sodium dodecyl sulfate. J Biol Chem (1971) 1.74
Distribution of high-conductance Ca(2+)-activated K+ channels in rat brain: targeting to axons and nerve terminals. J Neurosci (1996) 1.71
Structural basis of drug binding to L Ca2+ channels. Trends Pharmacol Sci (1998) 1.69
The leukotriene LTD4 receptor antagonist MK571 specifically modulates MRP associated multidrug resistance. Biochem Biophys Res Commun (1995) 1.68
Pathologic features of prostate cancer found at population-based screening with a four-year interval. J Natl Cancer Inst (2001) 1.63
Mutational spectrum in the Delta7-sterol reductase gene and genotype-phenotype correlation in 84 patients with Smith-Lemli-Opitz syndrome. Am J Hum Genet (2000) 1.61
Assay for calcium channels. Methods Enzymol (1985) 1.60
Visualization of the domain structure of an L-type Ca2+ channel using electron cryo-microscopy. J Mol Biol (2003) 1.56
7-Dehydrocholesterol-dependent proteolysis of HMG-CoA reductase suppresses sterol biosynthesis in a mouse model of Smith-Lemli-Opitz/RSH syndrome. J Clin Invest (2001) 1.55
Breast cancer screening in Navarra: interpretation of a high detection rate at the first screening round and a low rate at the second round. Int J Cancer (1997) 1.52
Local injection of the 90Y-labelled peptidic vector DOTATOC to control gliomas of WHO grades II and III: an extended pilot study. Eur J Nucl Med Mol Imaging (2002) 1.50
Molecular cloning and expression of the human delta7-sterol reductase. Proc Natl Acad Sci U S A (1998) 1.49
Mutations in the gene encoding 3 beta-hydroxysteroid-delta 8, delta 7-isomerase cause X-linked dominant Conradi-Hünermann syndrome. Nat Genet (1999) 1.47
Transfer of 1,4-dihydropyridine sensitivity from L-type to class A (BI) calcium channels. Neuron (1996) 1.46
Familial hemiplegic migraine mutations change alpha1A Ca2+ channel kinetics. J Biol Chem (1998) 1.44
Prediction of the effects and costs of breast-cancer screening in Germany. Int J Cancer (1994) 1.40
Polo-like kinase isoform expression is a prognostic factor in ovarian carcinoma. Br J Cancer (2004) 1.39
Reduction in breast cancer mortality due to the introduction of mass screening in The Netherlands: comparison with the United Kingdom. J Med Screen (1999) 1.39
Use of unlicensed nitric oxide in Austria. Lancet (1997) 1.38
High expression of RelA/p65 is associated with activation of nuclear factor-kappaB-dependent signaling in pancreatic cancer and marks a patient population with poor prognosis. Br J Cancer (2007) 1.37
Evidence of multiple receptor sites within the putative calcium channel. Naunyn Schmiedebergs Arch Pharmacol (1982) 1.37
How cost-effective is breast cancer screening in different EC countries? Eur J Cancer (1993) 1.35
Nation-wide breast cancer screening in The Netherlands: support for breast-cancer mortality reduction. National Evaluation Team for Breast Cancer Screening (NETB). Int J Cancer (1995) 1.34
Nation-wide breast cancer screening in The Netherlands: results of initial and subsequent screening 1990-1995. National Evaluation Team for Breast Cancer Screening. Int J Cancer (1998) 1.31
Identification of 1,4-dihydropyridine binding regions within the alpha 1 subunit of skeletal muscle Ca2+ channels by photoaffinity labeling with diazipine. Proc Natl Acad Sci U S A (1991) 1.31
Endogenous calcium channels in human embryonic kidney (HEK293) cells. Br J Pharmacol (1996) 1.31
(+)-Niguldipine binds with very high affinity to Ca2+ channels and to a subtype of alpha 1-adrenoceptors. Eur J Pharmacol (1989) 1.28
Purified skeletal muscle 1,4-dihydropyridine receptor forms phosphorylation-dependent oligomeric calcium channels in planar bilayers. Proc Natl Acad Sci U S A (1988) 1.28
The potential for isoenzyme-selective modulation of protein kinase C. FASEB J (1997) 1.28
A model-based prediction of the impact on reduction in mortality by a breast cancer screening programme in the city of Florence, Italy. Eur J Cancer (1995) 1.27
Diabetic retinopathy in type 1 diabetes-a contemporary analysis of 8,784 patients. Diabetologia (2011) 1.25
Properties of angiotensin II receptors in the bovine and rat adrenal cortex. J Biol Chem (1974) 1.25
Identification of a novel 1,4-dihydropyridine- and phenylalkylamine-binding polypeptide in calcium channel preparations. J Biol Chem (1987) 1.25
Early postoperative stress: video-assisted wedge resection/lobectomy vs conventional axillary thoracotomy. Chest (1996) 1.24
Topical corticosteroid therapy for acute radiation dermatitis: a prospective, randomized, double-blind study. Br J Dermatol (2002) 1.22
Binding of 3 H-desmethylphalloin to isolated plasma membranes from rat liver. Naunyn Schmiedebergs Arch Pharmacol (1972) 1.21
High affinity of sigma 1-binding sites for sterol isomerization inhibitors: evidence for a pharmacological relationship with the yeast sterol C8-C7 isomerase. Br J Pharmacol (1997) 1.20
Differential effects of Ca2+ channel beta1a and beta2a subunits on complex formation with alpha1S and on current expression in tsA201 cells. J Biol Chem (1998) 1.19
Interval cancers in the Dutch breast cancer screening programme. Br J Cancer (1999) 1.18
Calcium channels from Cyprinus carpio skeletal muscle. Proc Natl Acad Sci U S A (1991) 1.17
Solubilization and partial purification of putative calcium channels labelled with [3H]-nimodipine. Naunyn Schmiedebergs Arch Pharmacol (1983) 1.17
Colorectal cancer risk in adenoma patients: a nation-wide study. Int J Cancer (2004) 1.15
Subunit composition of brain voltage-gated potassium channels determined by hongotoxin-1, a novel peptide derived from Centruroides limbatus venom. J Biol Chem (1998) 1.15
Angiotensin II receptors in bovine adrenal cortex. Modification of angiotensin II binding by guanyl nucleotides. J Biol Chem (1974) 1.14
Genetic and serological heterogeneity of the supertypic HLA-B locus specificities Bw4 and Bw6. Immunogenetics (1989) 1.14
Purification of the putative calcium channel from skeletal muscle with the aid of [3H]-nimodipine binding. Naunyn Schmiedebergs Arch Pharmacol (1983) 1.13
Photoaffinity labelling of the phenylalkylamine receptor of the skeletal muscle transverse-tubule calcium channel. FEBS Lett (1987) 1.13
Identification of a phenylalkylamine binding region within the alpha 1 subunit of skeletal muscle Ca2+ channels. Proc Natl Acad Sci U S A (1990) 1.13
Three new familial hemiplegic migraine mutants affect P/Q-type Ca(2+) channel kinetics. J Biol Chem (2000) 1.12
Stereoselective photoaffinity labelling of the purified 1,4-dihydropyridine receptor of the voltage-dependent calcium channel. Eur J Biochem (1986) 1.12
Phenylalkylamine Ca2+ antagonist binding protein. Molecular cloning, tissue distribution, and heterologous expression. J Biol Chem (1995) 1.12
Modelling issues in cancer screening. Stat Methods Med Res (1995) 1.11
Identification of PK-A phosphorylation sites in the carboxyl terminus of L-type calcium channel alpha 1 subunits. Biochemistry (1996) 1.11
(-)-[3H]Desmethoxyverapamil, a novel Ca2+ channel probe. Binding characteristics and target size analysis of its receptor in skeletal muscle. FEBS Lett (1984) 1.11
Transfer of high sensitivity for benzothiazepines from L-type to class A (BI) calcium channels. J Biol Chem (1996) 1.10
Association of calcium channel alpha1S and beta1a subunits is required for the targeting of beta1a but not of alpha1S into skeletal muscle triads. Proc Natl Acad Sci U S A (1998) 1.09
Analysis of membrane protein self-association in lipid systems by fluorescence particle counting: application to the dihydropyridine receptor. Biochemistry (1997) 1.08
Susceptibility of multidrug-resistant human leukemia cell lines to human interleukin 2-activated killer cells. Cancer Res (1990) 1.08
Congenital sodium diarrhea is an autosomal recessive disorder of sodium/proton exchange but unrelated to known candidate genes. Gastroenterology (2000) 1.07
Mitochondrial translation of subunits of the rotenone-sensitive NADH:ubiquinone reductase in Neurospora crassa. EMBO J (1985) 1.07
The mysteries of sigma receptors: new family members reveal a role in cholesterol synthesis. Trends Pharmacol Sci (1997) 1.07
Conserved Ca2+-antagonist-binding properties and putative folding structure of a recombinant high-affinity dihydropyridine-binding domain. Biochem J (2000) 1.06
Renal receptors for calcitonin. Binding and degradation of hormone. J Biol Chem (1973) 1.06
Quebec randomized controlled trial on prostate cancer screening shows no evidence for mortality reduction. Prostate (1999) 1.04
Radiation risk of mammography related to benefit in screening programmes: a favourable balance? J Med Screen (1998) 1.04
Photoaffinity labelling of Ca2+ channels with [3H]azidopine. FEBS Lett (1984) 1.03
Veno-occlusive disease of the liver induced by gemcitabine. Ann Oncol (1998) 1.03
Identification of a 27-kDa high affinity phenylalkylamine-binding polypeptide as the sigma 1 binding site by photoaffinity labeling and ligand-directed antibodies. Mol Pharmacol (1993) 1.02
Nine L-type amino acid residues confer full 1,4-dihydropyridine sensitivity to the neuronal calcium channel alpha1A subunit. Role of L-type Met1188. J Biol Chem (1997) 1.02
Effects of the selective bisindolylmaleimide protein kinase C inhibitor GF 109203X on P-glycoprotein-mediated multidrug resistance. Br J Cancer (1996) 1.00
Differential labelling of putative skeletal muscle calcium channels by [3H]-nifedipine, [3H]-nitrendipine, [3H]-nimodipine and [3H]-PN 200 110. Naunyn Schmiedebergs Arch Pharmacol (1983) 0.99
The specific bisindolylmaleimide PKC-inhibitor GF 109203X efficiently modulates MRP-associated multiple drug resistance. Biochem Biophys Res Commun (1995) 0.98
Solid phase radioimmunoassay for cyclic AMP using staphylococcal protein A-antibody adsorbent. Naunyn Schmiedebergs Arch Pharmacol (1977) 0.98
Free flaps in the treatment of locally advanced malignancy of the scalp and forehead. Ann Plast Surg (2002) 0.98
Genetic defects in postsqualene cholesterol biosynthesis. Trends Endocrinol Metab (2000) 0.98
Regulation of the L-arginine-dependent and tetrahydrobiopterin-dependent biosynthesis of nitric oxide in murine macrophages. Eur J Biochem (1993) 0.98
A small isoform of NADH:ubiquinone oxidoreductase (complex I) without mitochondrially encoded subunits is made in chloramphenicol-treated Neurospora crassa. Eur J Biochem (1989) 0.97
Viscoelastic and aggregometric point-of-care testing in patients with septic shock - cross-links between inflammation and haemostasis. Acta Anaesthesiol Scand (2012) 0.97